Crohn’s Disease Therapeutics Market Size, Share, Analysis, Industry Report and Forecast 2019-2025
The global Crohn’s disease market is estimated to grow at a significant CAGR of 4.2% during the forecast period. Crohn's disease inflammation spreads into the layers of affected bowel tissues. Crohn's disease is painful and may lead to life-threatening complications. Anti-inflammatory drugs, immune system suppressors, antibiotics, anti-diarrheal medications, pain relievers, iron supplements are also used during the treatment and recovery of Crohn's disease. Crohn’s & Colitis Foundation launched a new open access journal in order to provide information to more than 3 million Americans living with IBD. Such platforms increase awareness among the population that further contribute to the growth of the market.
To Request a Sample of our Report on Crohn’s Disease Therapeutics Market: https://www.omrglobal.com/request-sample/crohns-disease-therapeutics-market
The market for Crohn’s disease is
growing due to the increasing prevalence of Chron’s disease across the globe.
The increasing prevalence of IBD results in the need for research for the
prevention of (Inflammatory Bowel Disease) IBD and innovations in healthcare
systems to manage this complex and costly disease. Crohn’s disease is an IBD
type that causes chronic inflammation and damage in the gastrointestinal (GI)
tract. Further, funding also leads to improving the quality of healthcare
facilities. In 2018, Crohn’s & Colitis Foundation has received a $3.3
million grant from The Leona M. and Harry B. Helmsley Charitable Trust to
support IBD Qorus, the Foundation’s flagship quality of care program. Further,
in 2018, Patient-Centered Outcomes Research Institute (PCORI) funded $2.4
million to Crohn’s & Colitis Foundation in order to study the comparative
effectiveness of biologic or small molecule therapies in IBD. Such funding
programs in order to increase awareness and R&D are contributing to market
growth.
(Get 15% Discount on Buying this Report)
A
full Report of Crohn’s Disease Therapeutics Market is Available at: https://www.omrglobal.com/industry-reports/crohns-disease-therapeutics-market
Global
Crohn’s disease Therapeutics Market Segmentation
·
Surgery
·
Anti-
Inflammatory Drug Administration
·
Steroids
·
Immunosuppressant
·
Biological
Drugs
·
Amino
salicylates
·
Others
Regional
Analysis
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of The World
Company
Profiles
·
Abbott
Laboratories
·
AbbVie
Inc.
·
Allergan,
PLC
·
Boehringer
Ingelheim International GmbH
·
Celgene
Corp.
·
Daiichi
Sankyo Co. Ltd.
·
Eli
Lilly and Co.
·
F.
Hoffmann-La Roche AG
·
GlaxoSmithKline
PLC
·
Johnson
& Johnson Services Inc.
·
Laboratory
Corporation of America Holdings
·
Mercator
Pharmaceutical Solutions
·
Pfizer
Inc.
·
Pharmacosmos
A/S
·
RPG
Life Sciences Ltd.
·
Sanofi
S.A.
·
Takeda
pharmaceutical Co., Ltd.
·
UCB,
Inc.
·
Vifor
Pharma Group
Reasons to Buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data, Request for
Report Customization @ https://www.omrglobal.com/report-customization/crohns-disease-therapeutics-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
For
More Information, Visit Orion Market Research
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment